Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation
MISSISSAUGA, Canada, April 16, 2018 /PRNewswire/ -- Nuvo Pharmaceuticals Inc. (OTCQX: NRIFF, TSX:NRI), based in Canada, focused on healthcare products and pharmaceuticals, today announced that the April 11th presentation from Jesse Ledger, Nuvo's President & CEO is now available for on-demand viewing at VirtualInvestorConferences.com.
LINK: https://tinyurl.com/0418postpr
Nuvo Pharmaceuticals Inc.'s presentation will be available 24/7 for 90 days. Investors and advisors may download shareholder materials from the "virtual trade booth" for the next three weeks.
Learn more about the event at www.VirtualInvestorConferences.com.
About Nuvo Pharmaceuticals Inc.
Nuvo (TSX: NRI; OTCQX: NRIFF) is a global commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo has four commercial products that are available in a number of countries: Pennsaid® 2%, Pennsaid, Resultz® and the heated lidocaine/tetracaine patch. Nuvo manufactures Pennsaid 2% for the U.S market, Pennsaid for the global market and the bulk drug product for the HLT Patch at its FDA, Health Canada and E.U. approved manufacturing facility in Varennes, Québec. The Company's focus is to maximize the value of Pennsaid 2% and Resultz through out-licensing to commercial partners in international markets and identifying new opportunities to acquire additional, accretive, late-stage products or businesses to further diversify the Company's existing product portfolio. For additional information, please visit www.nuvopharmaceuticals.com.
About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
SOURCE Nuvo Pharmaceuticals Inc.